Výsledky vyhledávání - Moore, Kathleen N

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer Autor Moore, Kathleen N., Monk, Bradley J.

Získat plný text Získat plný text Získat plný text

Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations Autor Moore, Kathleen N., Birrer, Michael J.

Získat plný text Získat plný text Získat plný text

Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age? Autor Birrer, Michael J., Betella, Ilaria, Martin, Lainie P., Moore, Kathleen N.

Získat plný text Získat plný text Získat plný text

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2 Autor Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.

Získat plný text Získat plný text Získat plný text

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers Autor Kunos, Charles A., Andrews, Stephen J., Moore, Kathleen N., Chon, Hye Sook, Ivy, S. Percy

Získat plný text Získat plný text Získat plný text

COST-EFFECTIVENESS OF NIRAPARIB, RUCAPARIB, AND OLAPARIB FOR TREATMENT OF PLATINUM-RESISTANT, RECURRENT OVARIAN CARCINOMA Autor WOLFORD, JULIET E., BAI, JIARU, MOORE, KATHLEEN N., KRISTELEIT, REBECCA, MONK, BRADLEY J., TEWARI, KRISHNANSU S.

Získat plný text Získat plný text Získat plný text

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion Autor Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle

Získat plný text Získat plný text Získat plný text

Suppressed expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma Autor Zakharov, Vladislav, Lin, Hsueh-Kung, Azzarello, Joseph, McMeekin, Scott, Moore, Kathleen N, Penning, Trevor M, Fung, Kar-Ming

Získat plný text Získat plný text

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders Autor Grisham, Rachel N., Moore, Kathleen N., Gordon, Michael S., Harb, Wael, Cody, Gwendolyn, Halpenny, Darragh F., Makker, Vicky, Aghajanian, Carol A.

Získat plný text Získat plný text Získat plný text

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary... Autor Coward, Jermaine I., Barve, Minal A., Kichenadasse, Ganessan, Moore, Kathleen N., Harnett, Paul R., Berg, Daniel, Garner, James S., Dizon, Don S.

Získat plný text Získat plný text Získat plný text

Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours Autor Moore, Kathleen N, Bauer, Todd M, Falchook, Gerald S, Chowdhury, Swapan, Patel, Chirag, Neuwirth, Rachel, Enke, Aaron, Zohren, Fabian, Patel, Manish R

Získat plný text Získat plný text Získat plný text

PROSPECTIVE EVALUATION OF MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER RISK INDEX SCORE FOR GYNECOLOGIC ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA Autor Gunderson, Camille C., Erickson, Britt. K., Wilkinson-Ryan, Ivy, Vesely, Sara K., Leath, Charles A., Gehrig, Paola A., Moore, Kathleen N.

Získat plný text Získat plný text Získat plný text

Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors Autor Bendell, Johanna C., Patel, Manish R., Moore, Kathleen N., Chua, Cynthia C., Arkenau, Hendrik‐Tobias, Dukart, Gary, Harrow, Kim, Liang, Chris

Získat plný text Získat plný text Získat plný text

A New Approach to Evaluate Drug Treatment Response of Ovarian Cancer Patients Based on Deformable Image Registration Autor Tan, Maxine, Li, Zheng, Qiu, Yuchen, McMeekin, Scott D., Thai, Theresa C., Ding, Kai, Moore, Kathleen N., Liu, Hong, Zheng, Bin

Získat plný text Získat plný text Získat plný text

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors Autor Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.

Získat plný text Získat plný text Získat plný text

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors Autor Moore, Kathleen N., Bendell, Johanna C., LoRusso, Patricia M., Olszanski, Anthony J., Zwick-Wallasch, Esther, Jansen, Mendel, Vandell, Alexander G., Senaldi, Giorgio

Získat plný text Získat plný text Získat plný text

A phase I–II evaluation of veliparib (NSC#737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: An NRG On... Autor Kunos, Charles, Deng, Wei, Dawson, Dawn, Lea, Jayanthi S., Zanotti, Kristine M., Gray, Heidi J., Bender, David P., Guaglianone, Perry P., Carter, Jori S., Moore, Kathleen N.

Získat plný text Získat plný text Získat plný text

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer Autor Gordhandas, Sushmita B., Manning-Geist, Beryl, Henson, Christina, Iyer, Gopa, Gardner, Ginger J., Sonoda, Yukio, Moore, Kathleen N., Aghajanian, Carol, Chui, M. Herman, Grisham, Rachel N.

Získat plný text Získat plný text Získat plný text

A Phase I Evaluation of Extended Field Radiation Therapy with Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women with Cervical Carcinom... Autor Boardman, Cecelia H, Brady, William E, Dizon, Don S, Kunos, Charles A, Moore, Kathleen N, Zanotti, Kristine M, Matthews, Cara, Cosin, Jonathan A, Aghajanian, Carol, Fracasso, Paula M

Získat plný text Získat plný text Získat plný text

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Per... Autor Moore, Kathleen N., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula A., Konner, Jason A., Perez, Raymond P., Bauer, Todd M., Ruiz-Soto, Rodrigo, Birrer, Michael J.

Získat plný text Získat plný text Získat plný text